Press release
Asia Pacific Vaccine Market to Generates US$ 17.82 billion by 2031., Japan Holds 14% Market Share | APAC Market Growth Projections
Asia Pacific Vaccine Market Size 2025
Asia Pacific vaccine market reached US$ 12.33 billion in 2023 and is expected to reach US$ 17.82 billion by 2031, growing at a CAGR of 6.1% during the forecast period 2024-2031.
Asia-Pacific (APAC), a powerhouse of economic growth that's also on the front lines of global health battles. Vaccines here aren't just medical tools-they're lifelines, protecting against everything from age-old foes like polio to modern pandemics like COVID-19. As we dive into the APAC vaccine market, we'll explore its booming growth, how shares are divided across key regions, and the driving forces propelling it forward
United States: Recent Industry Developments
✅ February 2026: Zimmer Biomet launched an advanced joint repair system targeting sports-related injuries, improving minimally invasive surgical outcomes.
✅ January 2026: Boston Scientific introduced wearable sensors for real-time monitoring of athlete recovery and injury prevention.
✅ December 2025: Mayo Clinic partnered with AI firms to integrate predictive analytics into sports medicine rehabilitation programs.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/asia-pacific-vaccine-market?kb
Japan: Recent Industry Developments
✅ February 2026: Olympus Corporation developed orthopedic surgical tools specifically for sports injury treatments.
✅ January 2026: Japan's National Sports Science Center expanded research on injury prevention technologies using motion capture and biomechanics.
✅ December 2025: Taisho Pharmaceutical launched nutraceuticals designed to support recovery from sports-related musculoskeletal injuries.
Major Top Key Players:
Serum Institute of India Pvt. Ltd., Bharat Biotech, CSL, GSK plc, Pfizer Inc., Biological E Limited., Takeda Pharmaceutical Company Limited., Sanofi, Merck & Co., Inc., and Abbott
Emerging Players
SINOVAC, Zhi Fei Biological, and Incepta Pharmaceuticals Ltd.
Key Developments:
United States - February 2026
Pfizer Inc. expanded its mRNA vaccine manufacturing collaboration with APAC biotech firms to strengthen regional supply resilience.
Moderna, Inc. announced technology transfer initiatives supporting localized mRNA production in Southeast Asia.
U.S. Food and Drug Administration (FDA) granted fast-track review for next-generation influenza vaccine candidates targeting APAC distribution.
Japan - January 2026
Takeda Pharmaceutical Company strengthened its dengue vaccine distribution partnerships across Southeast Asia.
Daiichi Sankyo expanded R&D investments in mRNA and recombinant vaccine platforms.
Japan's Ministry of Health accelerated approval timelines for pandemic preparedness vaccine stockpiling initiatives.
Europe - December 2025
GlaxoSmithKline plc enhanced vaccine adjuvant supply agreements to support APAC immunization programs.
Sanofi expanded pediatric combination vaccine exports to Asia-Pacific markets.
European Medicines Agency (EMA) approved updated seasonal vaccine formulations with export clearances to APAC nations.
Growth Forecast Projected:
The Asia-Pacific Vaccine Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Latest Mergers & Acquisitions (M&A)
Pfizer and Novavax vaccine partnership: Pfizer agreed a $530 million+ deal to license and collaborate with Novavax on vaccine technology (including Matrix-M adjuvant) - boosting its vaccine portfolio in Asia-Pacific and beyond (announced Jan 2026).
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=asia-pacific-vaccine-market?kb
Key Segmentations:
By Composition: Combination Vaccines, Mono Vaccines
By Type: CD30 Antibodies, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others
By Age Group: Pediatrics, Adults
By Route of Administration: Injectables, Oral, Others
By Application: Pneumococcal Disease, Pneumococcal Disease, Measles, Mumps & Varicella (Chickenpox), DPT (Diphtheria, Pertussis, Tetanus), Hepatitis, Influenza, Typhoid, Meningococcal Disease, Rabies Japanese Encephalitis, Yellow Fever, Others
By End-User: Hospitals & Specialty Clinics, Vaccination Centers, Others
Regional Analysis for Market:
🔹 China: 32% - Strong domestic manufacturing capacity and government-supported immunization programs.
🔹 India: 24% - Major global vaccine supplier with expanding public health initiatives.
🔹 Japan: 14% - Advanced R&D ecosystem and high adoption of innovative vaccines.
🔹 South Korea: 8% - Growing biotech sector and export-driven vaccine production.
🔹 Australia: 6% - Strong regulatory framework and stable immunization coverage.
🔹 Rest of Asia-Pacific: 16% - Rising investments in Southeast Asia and emerging healthcare markets.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/asia-pacific-vaccine-market?kb
Growth Drivers
✅ Surging Infectious Diseases
Asia-Pacific continues to face a heavy infectious disease burden - from dengue outbreaks in Southeast Asia to hepatitis cases in China. Recurring bacterial and viral threats, including lingering COVID variants, have heightened the urgency around immunization. Pneumococcal infections, in particular, remain widespread, prompting governments to ramp up funding, awareness drives, and vaccine distribution efforts.
✅ Government Immunization Programs and Investments
Large-scale national initiatives are playing a crucial role in expanding vaccine access. Programs such as India's Universal Immunization Programme and China's expanding HPV vaccination campaigns demonstrate strong government commitment. Backed by public-private partnerships and collaborations with global organizations like WHO, these efforts are improving coverage in rural and underserved communities while also encouraging domestic vaccine production.
✅ Technological Innovations
The rapid rise of mRNA technology - accelerated during the COVID-19 pandemic has transformed vaccine development timelines. This platform is now being explored for diseases such as RSV and even certain cancers. Conjugate vaccines continue to dominate due to their strong and lasting immune response, while recombinant and subunit vaccines are witnessing robust growth at a CAGR of 9.6%. Emerging DNA platforms and advanced adjuvants are further enhancing vaccine effectiveness, positioning the market for continued innovation.
✅ Rising Healthcare Expenditure and Awareness
As economies across Asia-Pacific strengthen, healthcare spending is increasing significantly. Countries are investing more in biotechnology research, particularly in innovation hubs like Singapore. Meanwhile, greater public awareness - driven by social media and post-pandemic health education - is encouraging more proactive vaccination, including adult and travel immunizations.
✅ Demographic and Economic Factors
The region's large and aging population is increasing demand for booster vaccines for conditions such as influenza and shingles. Rapid urbanization is also contributing to faster disease transmission, further underscoring the need for immunization. At the same time, strategic expansions and acquisitions by major pharmaceutical companies are accelerating market growth and improving vaccine accessibility across the region.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Contact Us For Custom Research: https://www.datamintelligence.com/custom-research?kb
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific Vaccine Market to Generates US$ 17.82 billion by 2031., Japan Holds 14% Market Share | APAC Market Growth Projections here
News-ID: 4395305 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Process Safety Services Market Forecast for Robust Expansion to USD 6.22 Billion …
Process Safety Services Market Size Was Valued at USD 4.01 Billion in 2023 and is Projected to Reach USD 6.22 Billion by 2032, Growing at a CAGR of 4.99% From 2024-2032.The growth of the Process Safety Services Market is primarily driven by increasingly stringent government regulations and industry standards aimed at preventing industrial accidents and ensuring workplace safety. Regulatory frameworks across sectors such as oil & gas, chemicals, pharmaceuticals, energy,…
Companion Animal Health Market Set for Explosive Growth to US$ 56.60 Billion by …
The Global Companion Animal Health Market reached US$ 25.38 billion in 2024 and is expected to reach US$ 56.60 billion by 2033, growing at a CAGR of 9.4% during 2025-2033.
Market growth is driven by rising pet ownership and humanization trends, surging demand for veterinary pharmaceuticals, diagnostics, and preventive care. Advancements in animal health technologies, expansion of pet insurance coverage, growing awareness of zoonotic diseases, and increasing e-commerce accessibility for pet…
Industry 4.0 Powers Process Automation Market Growth to USD Million by 2030, wit …
The Global Process Automation Market reached USD million in 2022 and is projected to witness lucrative growth by reaching up to USD million by 2030. The market is growing at a CAGR of 7.6% during the forecast period (2024-2031).The growth of the global process automation market is primarily driven by the increasing need for operational efficiency, cost reduction, and enhanced productivity across industries such as manufacturing, oil & gas, chemicals,…
Men's Vitality Supplements Market Set for Steady Growth to USD 11.21 Billion by …
The Global Men's Vitality Supplements Market, valued at US$ 6.53 billion in 2025 and projected to reach US$ 11.21 billion by 2033 at a CAGR of 6.99%, is primarily driven by rising health awareness among men and increasing demand for preventive healthcare solutions. Growing concerns related to low testosterone levels, stress-induced fatigue, reduced stamina, and age-related hormonal imbalances are encouraging men to adopt dietary supplements that enhance energy, immunity, and…
More Releases for Asia
Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value.
https://boomingfaucet.com/
Asia Private Equity Consulting
E-mail:nolan@pandacuads.com
In China,…
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,…
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022.
23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property…
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019".
The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn…
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia
Equipping Asia’s navies with the latest diving technology for asymmetric warfare and
operations
SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is
seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting…
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients.
Asked to comment on the move, Luke Palmer, the…
